openPR Logo
Press release

Platelet Rich Plasma Market - Global Industry Insights, trends, Outlook and opportunity Analysis, 2017 - 2025

10-23-2017 03:48 PM CET | Health & Medicine

Press release from: Biotechnology Report

Platelet Rich Plasma Market - Global Industry Insights, trends,

Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its wide application and no side effects. Platelet rich plasma is used for the treatment of injured tendons, muscle, joints, and ligaments. Use of PRP therapy on patients with low back pain helps them to recover. It is also widely used for the treatment for baldness, as PRP treatment increase the blood flow. In turn supporting the hair growth.

PRP treatment is accepted globally due to no side effects. PRP therapy can be used for various procedures, such as cosmetic surgery, orthopedics, and pain reliving treatment. Leukocyte rich PRP treatment has observed to show the highest growth, as it stimulates the growth of tissues, which helps in the treatment of soft tissue defects of human body in future. Orthopedics segment occupies the largest share in PRP market, as PRP helps in the treatment of various orthopedic disorders, such as knee osteoarthritis, achilles tendinopathy, and rotator cuff tears.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/936

Platelet Rich Plasma Market Taxonomy

On the basis of PRP type, the market is segmented into:

Pure-PRP
Leucocyte Rich PRP
Pure Platelet Rich Fibrin
Leukocyte-Rich PRF

On the basis of applications, the PRP market is segmented into:

Orthopedics
Cosmetic Surgery and Dermatology
Neurosurgery
General Surgery
Cardiothoracic Surgery
Urology
Ophthalmology

On the basis of origin, the PRP market is segmented into:

Autologous
Homologus
Allogeneic

Diversified use of platelet rich plasma to fuel the growth of market in near future

Increase in healthcare facilities for geriatric population and sports injuries has boosted the growth of the market. Increasing concern of the young population about the aesthetic appeal has propelled the market growth due to applications of PRP in cosmetic surgery. In 2016, there was increase of around 7% in non-surgical procedures of cosmetic surgery and PRP treatment, which is expected to boost the PRP market in near future.

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/platelet-rich-plasma-market-936

Emerging economies - major growth engines of the Platelet rich plasma market

The global platelet rich plasma market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America holds a dominant position in platelet rich plasma market due to advances in healthcare facilities and technology. Increase in cosmetic surgery, orthopedic surgeries, and sports injuries will support the growth of platelet rich plasma market in this region. According to the American society of plastic surgeons, in 2015, around 15.9 million cosmetic procedures are done in the U.S. According to Stop Sports Injuries report, there are around 2 million sports injuries takes place in high school athletes and more than 3.5 million kids under 14 years receive treatment for sports injury in the U.S. Europe is the second largest market for platelet rich plasma treatment. The rise in demand for cosmetic procedures across the economies is expected to boost the PRP treatment market. Asia Pacific is the third largest emerging market for PRP and this region has shown tremendous growth from past few years due to rise in geriatric population and demand for advanced cosmetic surgeries. According to the World Economic Forum, it is expected that geriatric population will be more than 2 billion by 2050.

Key players of platelet rich plasma market

Key players operating the platelet rich plasma market include Harvest Technologies Corporation, Biomet Inc., Arthrex Inc., Arteriocyte Medical systems, Dr. PRP America LLC, EmCyte Corporation, Regen Lab Sa, Exactech Inc., and Cesca Therapeutics Inc. Harvest Technologies Corporation, Arthrex Inc., and Biomet Inc. These are prominent player of the PRP market due to their efficient products and broad distribution network.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Platelet Rich Plasma Market - Global Industry Insights, trends, Outlook and opportunity Analysis, 2017 - 2025 here

News-ID: 781944 • Views: 306

More Releases from Biotechnology Report

Cancer Vaccines Market Size, Status Analysis, Growth & Forecast during 2017-2025
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Blood Clotting Factors Market - Enormous Benefits Forecast 2017 - 2025
Blood clotting factors are proteins or enzymes that control bleeding. Blood clotting or blood coagulation is a process in which blood gets converted into solid clots at time of any wound or break down of blood vessels. Clotting can prevent death from bleeding and also restrict the entry of bacteria and viruses into the body. Haemostasis is the mechanism for blood clotting, which in controlled by a number of factors
Major Acquisitions To Support The Growth In Synthetic Biology Market
Synthetic biology is a combination of biology and biomedical engineering principles that favors designing and construction of novel biological parts & systems and also the reconstruction of preexisting designs according to specific application requirements. Synthetic biology is extensively used in the field of medical and pharmaceuticals to produce and manufacture improved biological drugs and systems to meet various challenges in the healthcare sector. Synthetic biology offers various opportunities in the
Artificial Blood Market Development
Artificial Blood Market Potential According to the World Health Organization (WHO), there are around 50,000 stem cell transplantations performed annually worldwide, which include 2,000 cord blood hematopoietic stem cell transplants performed each year. Use of stem cells from cord blood is increasing, as it does not require perfect human leukocyte antigen (HLA) tissue matching, can be used allogenically, and has less incidence of graft v/s host disease. According to the New

All 5 Releases


More Releases for PRP

Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% …
New Study Report On "Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% | Analysis By PRP Type (P-PRP, L-PRP, L-PRF), By Players (DePuy Synthes, Stryker...), By Surgery (Orthopedic, Cosmetic, General...) & Region, Size & Forecast To 2023" The worldwide market for Platelet Rich Plasma (PRP) is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 400 million
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Plat …
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its
Global Platelet Rich Plasma (PRP) Industry
Global Platelet Rich Plasma (PRP) Industry Global PRP market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Harvest Technologies DePuy Synthes Stryker Zimmer Biomet Arthrex Exactech Emcyte Corporation Arteriocyte Adilyfe Try Sample Report @ https://www.wiseguyreports.com/sample-request/1140003-global-prp-market-research-report-2017 Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of PRP in
Platelet Rich Plasma (PRP) Market | Competitive Dynamics & Global Outlook 2024
Global Platelet Rich Plasma (PRP) Market: Overview Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration. PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel. PRP is an effective treatment to treat various diseases such as orthopedic diseases, sports injuries, neurological diseases and cardiothoracic diseases. In addition, PRP therapy has
Competitive Landscape for PRP Market Key Trends 2024
Global Platelet Rich Plasma (PRP) Market: Snapshot Of late, the global market for platelet rich plasma (PRP) has been witnessing a remarkable rise in its valuation. The upswing in the incidence of orthopedic diseases, propelled by the increasing cases of sports injuries, and the growing prevalence of cardiothoracic and neurological disorders has emerged as the main factor behind this tremendous growth of this market. In addition to this, the surge in cosmetic
Platelet Rich Plasma (PRP) Market- Global Industry Analysis 2016 - 2024
The global market for platelet rich plasma (PRP) has been witnessing a remarkable rise in its valuation. The upswing in the incidence of orthopedic diseases, propelled by the increasing cases of sports injuries, and the growing prevalence of cardiothoracic and neurological disorders has emerged as the main factor behind this tremendous growth of this market. In addition to this, the surge in cosmetic surgeries and the rising awareness level of people